GERN


Here’s Why Geron Corporation Shares Jumped Over 25% This Week

An article was published on Seeking Alpha detailing a long position.

Tuesday’s Movers: Shopify Inc (US) (SHOP) Soars, Houston American Energy Corporation (HUSA) Skyrockets, Geron Corporation (GERN) Sinks

    Shopify Inc (US) Shopify Inc (US) (NYSE:SHOP) shares are soaring nearly 10% in Tuesday’s trading session, following better-than-expectet second quarter earnings …

Company Update (NASDAQ:GERN): Geron Corporation Announces Third Quarter 2016 Financial Results and Recent Events

Geron Corporation (NASDAQ:GERN) reported financial results for the three and nine months ended September 30, 2016 and recent events. For the third quarter of …

Company Update (NASDAQ:GERN): Geron Corporation Provides Update on Imetelstat Trials Being Conducted by Janssen

Geron Corporation (NASDAQ:GERN) provided updates on the clinical trials being conducted by Janssen Research & Development, LLC, of the telomerase inhibitor imetelstat. Planned internal …

Stock Update (NASDAQ:GERN): Geron Corporation Announces Issuance of U.S. Patents Related to Imetelstat

Geron Corporation (NASDAQ:GERN) announced the recent issuance of three U.S.

Company Update (NASDAQ:GERN): Geron Corporation Reports Fourth Quarter and Annual 2015 Financial Results

Geron Corporation (NASDAQ:GERN) reported financial results for the fourth quarter and year ended December 31, 2015 and recent events. Fourth Quarter and Year-End 2015 …

Stock Update (NASDAQ:GERN): Geron Corporation Announces Initiation of Janssen Phase 2/3 Clinical Trial of Imetelstat in Myelodysplastic Syndromes

Geron Corporation (NASDAQ:GERN) announced the dosing of the first patient in a Phase 2/3 clinical trial to evaluate imetelstat in patients with myelodysplastic syndromes …

Wednesday Morning Pre-Market Insights: SanDisk Corporation (SNDK), Altria Group Inc (MO), Geron Corporation (GERN)

SanDisk Corporation (NASDAQ:SNDK) fell 1.33% in pre-market trading down to $54.

Company Update (NASDAQ:GERN): Geron Corporation Announces Initiation of Janssen Phase 2 Clinical Trial of Imetelstat in Myelofibrosis

Geron Corporation (NASDAQ:GERN) announced the dosing of the first patient in a Phase 2 clinical trial to evaluate imetelstat in patients with myelofibrosis (MF). This …

Oppenheimer Weighs in On Geron Corporation (GERN) Following ET and MF Study Publications

In a research report issued today, Oppenheimer’s healthcare analyst Ling Wang reiterated an Outperform rating on shares of Geron Corporation (NASDAQ:GERN) with a $5.50 …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts